Andrew Blumenfeld, MD: Long-Term OnabotulimuntoxinA Use in the COMPEL Study
May 20th 2020The director of the Headache Center of Southern California discussed the findings of the study, as well as what these data might suggest about how onabotulinumtoxinA fits into the shifting landscape of chronic migraine care.